Sabra S Inslicht
San Francisco VA Medical Center, San Francisco, CA
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Sabra S Inslicht as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:56 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT06788522 · The Effects of Orexin Antagonism on Fear Extinction in PTSDVA Office of Research and Development · recruiting · Insomnia, PTSD · principal investigator
- Ph4NCT03642028 · Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic StressVA Office of Research and Development · completed · Sleep Initiation and Maintenance Disorders, Stress Disorders, Posttraumatic · principal investigator
- Ph4NCT00674570 · Veteran Stress and Learning StudyVA Office of Research and Development · completed · Stress Disorders, Posttraumatic · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 03:56 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance inPosttraumatic StressI01CX001814 · VA · VETERANS AFFAIRS MED CTR SAN FRANCISCO · fiscal years 2019 to 2026Grant number is on one of their registry trials
- The Effects of Orexin Antagonism on Fear Extinction in PTSDI01CX002734 · VA · VETERANS AFFAIRS MED CTR SAN FRANCISCO · fiscal years 2025Grant number is on one of their registry trials
- Sex Differences in Fear Conditioning: Mechanisms of Risk and Resilience for PTSDI01CX000720 · VA · VETERANS AFFAIRS MED CTR SAN FRANCISCO · fiscal years 2014 to 2021Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 03:56 UTC. The ranking covers the 200 most relevant of 3 PubMed records, and a shared surname and initials can bring in a namesake. All 3 on PubMed
- Randomized controlled experimental study of hydrocortisone and D-cycloserine effects on fear extinction in PTSD.Neuropsychopharmacology · 202232 citationsRCR 3.2
- Psychophysiological treatment outcomes: Corticotropin-releasing factor type 1 receptor antagonist increases inhibition of fear-potentiated startle in PTSD patients.Psychophysiology · 202022 citationsRCR 1.5
- 22 citationsRCR 1.6